Phathom Pharmaceuticals Inc. (PHAT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Phathom Pharmaceuticals I...

NASDAQ: PHAT · Real-Time Price · USD
12.34
0.34 (2.83%)
At close: Sep 05, 2025, 3:59 PM
12.35
0.08%
After-hours: Sep 05, 2025, 06:51 PM EDT

Phathom Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
55.25M 682K n/a n/a
Cost of Revenue
7.97M 167K 620K 521K
Gross Profit
47.28M 515K -620K -521K
Operating Income
-277.47M -167.31M -172.44M -135.08M
Interest Income
15.16M 7.88M 2.13M 41K
Pretax Income
-334.33M -201.59M -197.72M -143.88M
Net Income
-334.33M -201.59M -223.01M -148.09M
Selling & General & Admin
290.66M 117.93M 101M 62.74M
Research & Development
34.08M 49.9M 71.44M 72.34M
Other Expenses
n/a n/a -110K n/a
Operating Expenses
324.75M 167.83M 172.44M 135.08M
Interest Expense
72.01M 41.97M 27.3M 6.79M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
332.72M 167.99M 172.44M 135.08M
Income Tax Expense
n/a n/a 25.28M 4.21M
Shares Outstanding (Basic)
63.18M 51.29M 39.12M 37M
Shares Outstanding (Diluted)
63.18M 51.29M 39.12M 37M
EPS (Basic)
-5.29 -3.93 -5.7 -4
EPS (Diluted)
-5.29 -3.93 -5.7 -4
EBITDA
-261.52M -159.05M -171.82M -134.56M
EBIT
-262.32M -159.62M -170.42M -137.09M
Depreciation & Amortization
795K 575K 620K 521K